Wang’s study showed that nasopharyngeal carcinoma patients with MEG3 rs10132552 CT genotype had a better response to treatment (OR = 0.261, p = 0.015) [19]. The gene discussed is MEG3; the disease is nasopharyngeal carcinoma.